Jury Awards First Successful Xarelto Verdict
Posted on behalf of Lynch Law Firm on Dec 19, 2017 in Class Actions News
Earlier this month, a Philadelphia state court jury ordered Johnson & Johnson and Bayer AG to pay $27.8 million to an Indiana couple for failing to warn of internal bleeding risks associated with the anticoagulant Xarelto.
The most recent lawsuit is the first trial win over Xarelto. The victim was awarded $1.8 million in actual damages and $26 million in punitive damages.
If you have been injured after being prescribed Xarelto or other anticoagulants, contact the Lynch Law Firm’s dedicated dangerous drug attorneys to schedule a free, no obligation consultation. We will review your claim and discuss the possibility of filing a Xarelto lawsuit to recover the compensation you deserve.
Why is Xarelto Dangerous?
In 2011, Xarelto was first approved by the U.S. Food and Drug Administration (FDA) to treat atrial fibrillation. It was initially promoted as a superior anticoagulant to Warfarin, a proven blood thinner that had been prescribed by doctors for decades.
The makers of Xarelto alleged that, unlike Warfarin, Xarelto does not require frequent dosage adjustments or for patients to follow a strict diet.
Although uncontrollable bleeding is a common side effect of blood thinners, there is no cure to stop bleeding caused by Xarelto. Many lawsuits allege this makes Xarelto defective and unreasonably dangerous.
In 2016, Xarelto generated $3.41 billion in revenue for Bayer AG and $2.2 billion for Johnson & Johnson making it one of the manufacturers’ most profitable product.
Victim Claims Xarelto Caused Severe Internal Bleeding
In the most recent Xarelto lawsuit, the 75-year-old victim took Xarelto for more than one year before she was hospitalized in 2014 for severe gastrointestinal bleeding. She was originally prescribed Xarelto to treat her atrial fibrillation and prevent strokes.
The victim reported that she underwent four blood transfusions because of the drug and switched to another blood thinner. She claims that she has not suffered any of the problems with her new blood thinner as she did when taking Xarelto.
The victim’s case claimed that Johnson & Johnson and Bayer AG failed to properly warn physicians and consumers of Xarelto’s risk of uncontrollable bleeding for certain patients.
Although Xarelto’s label warns patients internal bleeding can occur from use of the drug, the lawsuit claimed it does not fully warn consumers or doctors of the risks of bleeding out. This claim was corroborated by ex-FDA Chief David Kessler, who testified on behalf of the victim during the trial.
Previously, juries in federal courts in Mississippi and Louisiana ruled in favor of Johnson & Johnson and Bayer AG, stating Xarelto’s label properly warned consumers of the potential bleeding risks.
Currently, there are more than 20,000 Xarelto lawsuits pending against Johnson & Johnson and Bayer AG. The FDA has linked 370 deaths to the use of the drug. More than 18,500 of these cases are currently pending in federal court where they have been consolidated into multidistrict litigation.
Officials from Johnson & Johnson and Bayer announced the companies intend to appeal the most recent jury decision.
Contact an Experienced Defective Drug Lawyer
If you suffered adverse side effects after taking Xarelto, you may be entitled to pursue compensation for your medical expenses, lost income, and pain and suffering.
The personal injury lawyers at Lynch Law Firm can talk to you about the possibility of filing a Xarelto lawsuit during a free initial consultation.
Our experienced attorneys can pursue compensation against negligent drug manufacturers who failed to properly inform patients of the risks associated with their products. We only work on a contingency fee basis, which means you will only have to pay us if we secure compensation on your behalf.
Call (800) 518-0508 to schedule a free consultation.
Free Case Review
Class Actions News